ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 19 filers reported holding ENDOLOGIX INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $201,000 | -48.3% | 210,000 | -48.1% | 0.00% | – |
| Q1 2017 | $389,000 | +7.2% | 405,000 | 0.0% | 0.00% | – |
| Q4 2016 | $363,000 | -44.0% | 405,000 | -39.9% | 0.00% | -100.0% |
| Q3 2016 | $648,000 | +33.6% | 674,000 | +24.8% | 0.00% | – |
| Q3 2014 | $485,000 | +20.3% | 540,000 | +27.1% | 0.00% | – |
| Q1 2014 | $403,000 | – | 425,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 51,117,000 | $46,140,000 | 1.90% |
| PFM Health Sciences, LP | 6,445,000 | $5,809,000 | 0.16% |
| Partner Investment Management, L.P. | 84,000 | $76,000 | 0.10% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,562,000 | $5,013,000 | 0.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,000,000 | $5,423,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,095,000 | $1,004,000 | 0.04% |
| ACUTA CAPITAL PARTNERS, LLC | 96,000 | $86,000 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,500,000 | $1,352,000,000 | 0.03% |
| AMUNDI ASSET MANAGEMENT US, INC. | 7,305,000 | $6,557,000 | 0.02% |
| Citadel Advisors | 6,230,000 | $5,624,000 | 0.01% |